Femasys

Femasys EBITDA per Share

The EBITDA per Share of Femasys (FEMY) as of Oct 19, 2026 is -8.51 USD. In the previous year, EBITDA per Share was -15.34 USD — a change of -44.50% (higher).

EBITDA per Share

-8.51USD

YoY

-44.50%

Last updated:

EBITDA per Share of Femasys is 2025 -8.51 USD. EBITDA per Share of Femasys was 2024 -15.34 USD. It decreases by -44.50% higher compared to the previous year.

The Femasys EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2019
-3.28 USD
Jan 1, 2020
-13.73 USD
Jan 1, 2021
-13.13 USD
Jan 1, 2022
-18.71 USD
Jan 1, 2023
-12.95 USD
Jan 1, 2024
-15.34 USD
Jan 1, 2025
-8.51 USD
The Femasys EBITDA per Share history
YEAREBITDA per ShareYoY
-8.51USD-44.50%
-15.34USD+18.45%
-12.95USD-30.76%
-18.71USD+42.49%
-13.13USD-4.35%
-13.73USD+318.60%
-3.28USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Femasys Stock analysis

What does Femasys do? Femasys Inc., based in Suwanee, Georgia, is a biomedical company operating in the Health Care sector. It develops non-surgical reproductive healthcare solutions, including FemBloc for permanent birth control and FemaSeed for artificial insemination. The company employs 34 full-time staff and went public on 18 June 2021. Its products aim to improve patient care and health economics through office-based treatments, with FemBloc utilizing dual intrauterine delivery and FemaSeed offering single intrauterine directional delivery for infertility treatment. Femasys is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Femasys stock

EBITDA per Share of Femasys is -8.51 USD in 2025.

EBITDA per Share of Femasys changed from -15.34 USD to -8.51 USD, representing a -44.50% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Femasys since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Femasys

All Key Metrics — Femasys